| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2006 | Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor - An aid in differential diagnosis | TSUI-LIEN MAO ; Seidman J.D.; Kurman R.J.; Shih I.-M. | American Journal of Surgical Pathology | 59 | 55 | |
| 2009 | Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases | Veras E.; TSUI-LIEN MAO ; Ayhan A.; Ueda S.; Lai H.; Hayran M.; Shih I.-M.; Kurman R.J. | American Journal of Surgical Pathology | 100 | 85 | |
| 2010 | DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma | Kuo K.-T.; TSUI-LIEN MAO ; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L. | Clinical Cancer Research | 65 | 68 | |
| 2010 | DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma | KUAN-TING KUO ; Mao T.-L.; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L. | Clinical Cancer Research | 65 | 68 | |
| 2012 | Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A | Wu C.H.; TSUI-LIEN MAO ; Vang R.; Ayhan A.; Wang T.-L.; Kurman R.J.; Shih I.-M. | International Journal of Gynecological Pathology | 47 | 40 | |
| 2006 | Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma | TSUI-LIEN MAO ; Hsu C.-Y.; Yen M.J.; Gilks B.; Sheu J.J.-C.; Gabrielson E.; Vang R.; Cope L.; Kurman R.J.; Wang T.-L.; Shih I.-M. | Human Pathology | 32 | 32 | |
| 2009 | Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma | Kuo K.-T.; TSUI-LIEN MAO ; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. | American Journal of Pathology | 303 | 276 | |
| 2009 | Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma | KUAN-TING KUO ; Mao T.-L.; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. | American Journal of Pathology | 303 | 286 | |
| 2010 | Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma | Jones S.; Wang T.-L.; Shih I.-M.; TSUI-LIEN MAO ; Nakayama K.; Roden R.; Glas R.; Slamon D.; Diaz Jr. L.A.; Vogelstein B.; Kinzler K.W.; Velculescu V.E.; Papadopoulos N. | Science | 792 | 762 | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. | Cancer | 16 | 17 | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | Cheng W.-F.; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN ; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. | Cancer | 16 | 17 | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; WEN-YIH TSENG ; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. | Cancer | 16 | 17 | |
| 2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; CHANG-YAO HSIEH ; Shih I.-M.; Wang T.-L.; Wu T.-C. | Cancer | 17 | ||
| 2008 | HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions | Mao T.-L.; Kurman R.J.; YUNG-MING JENG ; Huang W.; Shih I.-M. | American Journal of Surgical Pathology | 32 | 28 | |
| 2008 | HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions | TSUI-LIEN MAO ; Kurman R.J.; Jeng Y.-M.; Huang W.; Shih I.-M. | American Journal of Surgical Pathology | 32 | 29 | |
| 2012 | Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses | Kuhn E.; Wu R.-C.; Guan B.; Wu G.; Zhang J.; Wang Y.; Song L.; Yuan X.; Wei L.; Roden R.B.S.; KUAN-TING KUO ; Nakayama K.; Clarke B.; Shaw P.; Olvera N.; Kurman R.J.; Levine D.A.; Wang T.-L.; Shih I.-M. | Journal of the National Cancer Institute | 148 | 142 | |
| 2009 | IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype | Köbel M.; Xu H.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO ; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D.; Gilks C.B. | Modern Pathology | 94 | 88 | |
| 2007 | Immunohistochemistry of choriocarcinoma: An aid in differential diagnosis and in elucidating pathogenesis | TSUI-LIEN MAO ; Kurman R.J.; Huang C.-C.; Lin M.-C.; Shih I.-M. | American Journal of Surgical Pathology | 58 | 56 | |
| 2015 | Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors | Ayhan A.; TSUI-LIEN MAO ; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. | Journal of Pathology: Clinical Research | 12 | 12 | |
| 2015 | Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules | Yu Y.; Gaillard S.; Phillip J.; TAI-CHUNG HUANG ; Pinto S.; Tessarollo N.; Zhang Z.; Pandey A.; Wirtz D.; Ayhan A.; Davidson B.; Wang T.-L.; Shih I.-M. | Cancer Cell | 69 |
